Literature DB >> 10433496

Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.

D R Varma1, H Shen, X F Deng, K G Peri, S Chemtob, S Mulay.   

Abstract

1. Negative inotropic effects of several beta-adrenoceptor (betaAR) antagonists on electrically-stimulated right atria, left atria, right ventricles and left ventricular papillary muscles from reserpine-treated rats were used as a measure of their inverse agonist activities. 2. Beta1AR antagonists acebutolol, atenolol and metoprolol, beta2AR antagonist ICI-181,551 and nonselective betaAR antagonists alprenolol, nadolol, propranolol and timolol produced negative inotropic effects, which were most marked on the right atria. 3. The nonselective betaAR antagonist pindolol did not exhibit inverse agonist activity but inhibited the negative inotropic activities of ICI-118,551, atenolol and propranolol. 4. The negative inotropic effects of lidocaine, nifedipine and pentobarbitone were similar on all the four myocardial preparations. 5. The positive inotropic efficacy of salbutamol on right and left atria but not on right ventricles and papillary muscles was comparable to that of isoprenaline. The antagonist activity of ICI-118,551 against isoprenaline was greater on right atria than on other cardiac regions. 6. Beta1AR proteins were expressed in all regions of the heart but of beta2AR were primarily localized in the right atrium. 7. It is concluded that beta2AR play a greater role in right atria than in other cardiac regions and almost all betaAR antagonists behave as inverse agonists.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433496      PMCID: PMC1566092          DOI: 10.1038/sj.bjp.0702616

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  Reverse intrinsic activity of antagonists on G protein-coupled receptors.

Authors:  W Schütz; M Freissmuth
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

Review 2.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 3.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins.

Authors:  R J Lefkowitz; S Cotecchia; P Samama; T Costa
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

4.  Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.

Authors:  P Samama; G Pei; T Costa; S Cotecchia; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

5.  The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).

Authors:  A J Bilski; S E Halliday; J D Fitzgerald; J L Wale
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

6.  Agonist-independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells.

Authors:  R Hanf; Y Li; G Szabo; R Fischmeister
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

7.  Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors.

Authors:  T Mewes; S Dutz; U Ravens; K H Jakobs
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

8.  Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes.

Authors:  G Hilf; K H Jakobs
Journal:  Eur J Pharmacol       Date:  1992-03-12       Impact factor: 4.432

9.  Delineation of the distribution of beta-adrenergic receptor subtypes in canine myocardium.

Authors:  S S Murphree; J E Saffitz
Journal:  Circ Res       Date:  1988-07       Impact factor: 17.367

10.  Inverse agonist activity of beta-adrenergic antagonists.

Authors:  P Chidiac; T E Hebert; M Valiquette; M Dennis; M Bouvier
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

View more
  13 in total

1.  Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol.

Authors:  Francesca Rochais; Jean-Pierre Vilardaga; Viacheslav O Nikolaev; Moritz Bünemann; Martin J Lohse; Stefan Engelhardt
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Effects of cardiac output on the initial distribution volume of glucose in the absence of fluid gain or loss in pigs.

Authors:  Toshinori Kasai; Eiji Hashiba; Junichi Saito; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2016-10-26       Impact factor: 2.078

3.  Modeling the effects of β1-adrenergic receptor blockers and polymorphisms on cardiac myocyte Ca2+ handling.

Authors:  Robert K Amanfu; Jeffrey J Saucerman
Journal:  Mol Pharmacol       Date:  2014-05-27       Impact factor: 4.436

4.  The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells.

Authors:  Hui Peng; Richard A Bond; Brian J Knoll
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-12       Impact factor: 3.000

5.  Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.

Authors:  Michio Nakaya; Satsuki Chikura; Kenji Watari; Natsumi Mizuno; Koji Mochinaga; Supachoke Mangmool; Satoru Koyanagi; Shigehiro Ohdo; Yoji Sato; Tomomi Ide; Motohiro Nishida; Hitoshi Kurose
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

6.  Propranolol targets the contractility of infantile haemangioma-derived pericytes.

Authors:  D Lee; E Boscolo; J T Durham; J B Mulliken; I M Herman; J Bischoff
Journal:  Br J Dermatol       Date:  2014-08-28       Impact factor: 9.302

7.  Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats.

Authors:  Christian Höcht; Carla Di Verniero; Javier A W Opezzo; Carlos A Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-22       Impact factor: 3.000

8.  Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.

Authors:  R A Ngala; J O'Dowd; S J Wang; A Agarwal; C Stocker; M A Cawthorne; J R S Arch
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

9.  β2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.

Authors:  Jian Luo; Yuan-Hua Liu; Wei Luo; Zhu Luo; Chun-Tao Liu
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

10.  Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.

Authors:  Stephanie M Ravenscroft; Amy Pointon; Awel W Williams; Michael J Cross; James E Sidaway
Journal:  Toxicol Sci       Date:  2016-04-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.